LifeMD Inc.’s stock LFMD soared 9% early Wednesday, after the virtual primary care provider said it’s teaming up with Medifast Inc. MED, a wellness company known for its habit-based and coach-guided lifestyle service Optavia, to create a clinically supported weight management program that will include the new class of weight-loss drugs called GLP-1. The drugs developed by Eli Lilly & Co. LLY and Denmark’s Novo Nordisk NVODK:NOVO.B are named after a gut hormone that they mimic to control...

Comment

Become a member to take advantage of more features, like commenting and voting.

Jobs to Watch